Commerce Bank’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $890K | Sell |
18,568
-2,933
| -14% | -$126K | ﹤0.01% | 782 |
|
|
2026
Q1 | $790K | Buy |
21,501
+1,971
| +10% | +$93.4K | ﹤0.01% | 793 |
|
|
2025
Q4 | $994K | Sell |
19,530
-1,399
| -7% | -$71.5K | 0.01% | 674 |
|
|
2025
Q3 | $1.16M | Sell |
20,929
-1,853
| -8% | -$108K | 0.01% | 634 |
|
|
2025
Q2 | $1.57M | Sell |
22,782
-274
| -1% | -$18.6K | 0.01% | 530 |
|
|
2025
Q1 | $1.6M | Sell |
23,056
-8,603
| -27% | -$711K | 0.01% | 510 |
|
|
2024
Q4 | $2.72M | Sell |
31,659
-875
| -3% | -$94.6K | 0.02% | 435 |
|
|
2024
Q3 | $3.87M | Buy |
32,534
+4,489
| +16% | +$599K | 0.02% | 372 |
|
|
2024
Q2 | $4M | Buy |
28,045
+2,501
| +10% | +$331K | 0.03% | 345 |
|
|
2024
Q1 | $3.28M | Sell |
25,544
-1,035
| -4% | -$123K | 0.02% | 406 |
|
|
2023
Q4 | $2.75M | Buy |
26,579
+3,703
| +16% | +$366K | 0.02% | 425 |
|
|
2023
Q3 | $2.08M | Sell |
22,876
-678
| -3% | -$59.7K | 0.02% | 442 |
|
|
2023
Q2 | $1.91M | Sell |
23,554
-158
| -0.7% | -$12.9K | 0.01% | 461 |
|
|
2023
Q1 | $1.89M | Sell |
23,712
-238
| -1% | -$16.9K | 0.01% | 439 |
|
|
2022
Q4 | $1.62M | Sell |
23,950
-670
| -3% | -$39.3K | 0.01% | 469 |
|
|
2022
Q3 | $1.23M | Buy |
24,620
+744
| +3% | +$39.9K | 0.01% | 510 |
|
|
2022
Q2 | $1.33M | Buy |
23,876
+820
| +4% | +$45.5K | 0.01% | 513 |
|
|
2022
Q1 | $1.28M | Sell |
23,056
-52
| -0.2% | -$2.67K | 0.01% | 545 |
|
|
2021
Q4 | $1.29M | Sell |
23,108
-398
| -2% | -$21.6K | 0.01% | 564 |
|
|
2021
Q3 | $1.13M | Buy |
23,506
+518
| +2% | +$25K | 0.01% | 579 |
|
|
2021
Q2 | $963K | Sell |
22,988
-478
| -2% | -$18.5K | 0.01% | 620 |
|
|
2021
Q1 | $791K | Buy |
23,466
+5,384
| +30% | +$192K | 0.01% | 664 |
|
|
2020
Q4 | $632K | Buy |
18,082
+570
| +3% | +$19.7K | 0.01% | 696 |
|
|
2020
Q3 | $608K | Sell |
17,512
-15,960
| -48% | -$532K | 0.01% | 637 |
|
|
2020
Q2 | $1.1M | Buy |
33,472
+15,344
| +85% | +$490K | 0.01% | 486 |
|
|
2020
Q1 | $546K | Buy |
18,128
+3,086
| +21% | +$91.9K | 0.01% | 557 |
|
|
2019
Q4 | $435K | Buy |
15,042
+1,904
| +14% | +$52.7K | ﹤0.01% | 690 |
|
|
2019
Q3 | $340K | Sell |
13,138
-2,720
| -17% | -$68.8K | ﹤0.01% | 738 |
|
|
2019
Q2 | $404K | Sell |
15,858
-1,454
| -8% | -$35.9K | ﹤0.01% | 674 |
|
|
2019
Q1 | $453K | Buy |
17,312
+924
| +6% | +$22.7K | 0.01% | 594 |
|
|
2018
Q4 | $378K | Buy |
16,388
+504
| +3% | +$11.2K | ﹤0.01% | 619 |
|
|
2018
Q3 | $374K | Sell |
15,884
-114
| -0.7% | -$2.78K | ﹤0.01% | 671 |
|
|
2018
Q2 | $369K | Buy |
15,998
+322
| +2% | +$7.65K | ﹤0.01% | 663 |
|
|
2018
Q1 | $386K | Sell |
15,676
-58
| -0.4% | -$1.52K | 0.01% | 645 |
|
|
2017
Q4 | $422K | Buy |
15,734
+1,306
| +9% | +$33.2K | 0.01% | 621 |
|
|
2017
Q3 | $348K | Buy |
14,428
+3,916
| +37% | +$88.5K | ﹤0.01% | 660 |
|
|
2017
Q2 | $226K | Buy |
+10,512
| New | +$212K | ﹤0.01% | 766 |
|
|
2016
Q4 | – | Sell |
-11,252
| Closed | -$234K | – | 829 |
|
|
2016
Q3 | $234K | Sell |
11,252
-4,324
| -28% | -$107K | ﹤0.01% | 726 |
|
|
2016
Q2 | $418K | Sell |
15,576
-1,438
| -8% | -$39.4K | 0.01% | 548 |
|
|
2016
Q1 | $461K | Buy |
17,014
+1,592
| +10% | +$42.7K | 0.01% | 516 |
|
|
2015
Q4 | $448K | Sell |
15,422
-422
| -3% | -$11.7K | 0.01% | 517 |
|
|
2015
Q3 | $430K | Sell |
15,844
-520
| -3% | -$14.7K | 0.01% | 533 |
|
|
2015
Q2 | $448K | Sell |
16,364
-252
| -2% | -$7.08K | 0.01% | 553 |
|
|
2015
Q1 | $444K | Buy |
16,616
+50
| +0.3% | +$1.15K | 0.01% | 563 |
|
|
2014
Q4 | $351K | Hold |
16,566
| – | – | 0.01% | 629 |
|
|
2014
Q3 | $394K | Sell |
16,566
-1,294
| -7% | -$29.8K | 0.01% | 569 |
|
|
2014
Q2 | $413K | Buy |
17,860
+1,760
| +11% | +$38.9K | 0.01% | 569 |
|
|
2014
Q1 | $367K | Sell |
16,100
-3,340
| -17% | -$71.2K | 0.01% | 586 |
|
|
2013
Q4 | $359K | Sell |
19,440
-180
| -0.9% | -$3.14K | 0.01% | 571 |
|
|
2013
Q3 | $332K | Sell |
19,620
-5,570
| -22% | -$93.7K | 0.01% | 578 |
|
|
2013
Q2 | $390K | Buy |
+25,190
| New | +$419K | 0.01% | 532 |
|
Other funds holding NVO
F
Commerce Bank's NVO Position: Q2 2026 in Review
Commerce Bank reduced its Novo Nordisk (NVO) stake by 14% in Q2 2026, selling an estimated $126K and leaving 18,568 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #782.
Commerce Bank first reported a position in NVO in Q2 2013 and has held it in 51 quarters since. The position peaked at $4M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Commerce Bank held 18,568 shares of Novo Nordisk worth $890K as of Q2 2026.
- Commerce Bank sold 2,933 Novo Nordisk shares in Q2 2026, an estimated $126K.
- Novo Nordisk made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #782 holding.
- Commerce Bank first reported a position in Novo Nordisk in Q2 2013 and has held it in 51 quarters since.
- Commerce Bank's Novo Nordisk position peaked at $4M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.